月經週期中子宮內膜準備好接受胚胎植入的這段時間稱為「著床窗期」。
不過不是每一位女性的著床窗期都是一樣的，至少 30% 的女性著床窗期早於或晚於平均值，即使植入最好的胚胎，錯過最佳時機也可能導致無法成功著床。
ora™ 是全球唯一的非侵入性著床窗期 (WOI) 檢測技術，使用血液檢體評估備孕媽媽的最佳植入胚胎時間點， 提高試管嬰兒療程 (IVF) 的成功懷孕率。
非侵入式
以新式抽血採檢方式替代刮取子宮內膜組織，免去舊式侵入性採檢帶給備孕媽媽的疼痛不適感。
透過已累積近千例的臨床檢體資料庫，驗證ora™ 預測受孕窗期具有>95%的準確率。同時，透過血液中穩定表現的miRNA生物標記組合，降低檢體品質不佳導致檢體失敗的機率(<1%)。
提升治療效率 :
ora™ 提供的使用方式可免去傳統採樣需要額外的模擬療
程 ，為您省去寶貴時間與費用。ora™ 能夠在胚胎植入當天同時收集血液樣本，不需要額外進行模擬療程，不但可以省去備孕媽媽一個月以上的寶貴的時間，也能減少額外藥物費用 。
降低重新採樣機率：
窗期檢測的結果會分為，容受期前(PRE)、容受期(WOI)、容受後(POST)。其中在容受期後(POST)代表著採樣時內膜細胞已經進入衰退階段。為了能夠確認已過容受期多久，傳統組織採樣的窗期檢測會建議再一個模擬週期，並提前 24 小時進行第二次採樣。對備孕媽媽來說，就需要再花費一個周期的時間與金錢成本。而非侵入式 ORA 解決了這個困難，是唯一可以透過同一個週期，兩個時間點抽血，避免需要額外模擬療程進行第二次採檢的可能。
什麼是宮喜方案？
在冷凍胚胎植入週期，胚胎植入當週抽血，透過英緹生技保存血液檢體。如果需要再次安排植入胚胎，備孕媽媽可以選擇啟動預先保存的血液檢體進行子宮內膜容受性檢測，無需於額外的模擬週期抽取血液檢體。
We are proud of our patients who have worked tirelessly towards creating their families. We’re excited to share what they have to say about their experience using Inti Labs’ endometrial receptivity tests.
We are proud of our patients who have worked tirelessly towards creating their families. We’re excited to share what their doctors have to say about their experience using Inti Labs’ endometrial receptivity tests.
“One of our patients had experienced several failed implantations and was down to her last viable embryo. After using ORA™, we received a Pre-Receptive result, meaning her window of implantation was 24 hours later than expected. Following ORA™’s recommendation for adjusted timing, her final embryo transfer and subsequent implantation was successful and is an ongoing healthy pregnancy. The process was simple and patient-friendly — taking a blood sample is so much easier than an endometrial sample — and the benefits of a smoother and more comfortable experience for patients cannot be overstated. We look forward to continue offering our RIF patients a renewed chance at parenthood with the critical insights ORA™ provides.”
– Dr. Tran Nguyen, Modbury Hospital
“MIRA™ has changed the way I manage my patients with RIF. Comprehensive, precise, and low volume tissue sample requirements are the main advantages.”
-Dr. Liza Ling Ping, TMC Fertility
